References
- Jones R K, Henshaw S K. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden. Perspect Sex Reprod Health May, 2002; 34(3)154–161, June
- Schaff E A, Fielding S L. A comparison of the Abortion Rights Mobilization and Population Council trials. J Am Med Womens Assoc 2000; 55(3 Suppl)137–140
- Harper C, Ellertson C, Winikoff B. Could American women use mifepristone-misoprostol pills safely with less medical supervision?. Contraception Feb, 2002; 65(2)133–142
- Baird D T. Medical abortion in the first trimester. Best Pract Res Clin Obstet Gynaecol Apr, 2002; 16(2)221–236
- Meckstroth K R, Darney P D. Prostaglandins for first-trimester termination. Best Pract Res Clin Obstet Gynaecol Oct, 2003; 17(5)745–763
- Kulier R, Gulmezoglu A, Hofmeyr G, et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004; 2, CD002855
- Schaff E A, Fielding S L, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. JAMA Oct 18, 2000; 284(15)1948–1953
- Elul B, Pearlman E, Sorhaindo A, et al. In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol. J Am Med Women's Assoc 2000; 55(3 Suppl)169–172
- Schaff E A, Fielding S L, Eisinger S H, et al. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception Jan, 2000; 61(1)41–46
- Schaff E A, Eisinger S H, Stadalius L S, et al. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception Jan, 1999; 59(1)1–6
- Schaff E A, Stadalius L S, Eisinger S H, et al. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract Apr, 1997; 44(4)353–360
- Guengant J P, Bangou J, Elul B, et al. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Contraception Sep, 1999; 60(3)167–172
- Elul B, Hajri S, Ngoc N N, et al. Can women in less-developed countries use a simplified medical abortion regimen?. Lancet May 5, 2001; 357(9266)1402–1405
- Fiala C, Winikoff B, Helstrom L, et al. Acceptability of home-use of misoprostol in medical abortion. Contraception Nov, 2004; 70(5)387–392
- Ashok P W, Templeton A, Wagaarachchi P T, et al. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG Nov, 2002; 109(11)1281–1289
- Hausknecht R U. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med Aug 31, 1995; 333(9)537–540
- Borgatta L, Mullally B, Vragovic O, et al. Misoprostol as the primary agent for medical abortion in a low-income urban setting. Contraception Aug, 2004; 70(2)121–126
- Carbonell JL Esteve, Varela L, Velazco A, et al. Vaginal misoprostol for late first trimester abortion. Contraception May, 1998; 57(5)329–333
- Creinin M D. Oral methotrexate and vaginal misoprostol for early abortion. Contraception Jul, 1996; 54(1)15–18
- Stewart P, Fletcher J, Sharma A. Report from the Faculty of Family Planning and Reproductive Health Care AGM, May 2003: Medical termination of pregnancy in the late first trimester. J Fam Plann Reprod Health Care Oct, 2003; 29(4)243–244